Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

EPL Investor Presentation: Key Takeaways

Q2FY27 consolidated revenue ₹15,674mn (+30.0%), EBITDA ₹2,960mn (+17.6%, 18.9% margin), PAT ₹1,101mn (+5.6%). Personal Care & Beyond scaling; Indovida merger pending.

EPL Q2 FY27 concall: date, live audio and summaryConcall page →
Highlights
Revenue growth+30.0% YoY to ₹15,674mn
MarginsReported EBITDA 18.9% vs 20.9%; underlying 20.4%
Demand visibilityRobust demand pipeline; B&C momentum continues across regions

Growth

Revenue +30.0% to ₹15,674mn; EAP +40.2%, India +30.5%, Europe +30.4%. PAT +5.6%; underlying EBITDA margin 20.4%.

Outlook

No numeric guidance; expects PAT growth to recover in coming quarters. YTD capex ₹3,150mn (vs ₹1,681mn); Indovida merger pending NCLT.

Risks

Europe EBITDA -2.9% with 10.4% margin; Middle East-driven input inflation; higher depreciation, ETR, FX losses; net debt ₹6,562mn.

Last quarter's promises, checked

Delivered

  • Guided high-teens rev growth → +30.0% (= BEAT)
  • Guided ~20% underlying EBITDA margin → 20.4% (= BEAT)
  • Guided full cost pass-through → achieved via pricing (= BEAT)

Partly delivered

  • Guided double-digit FY PAT growth → Q2 +5.6%, Q1 -1.4% (= PARTIAL)
  • Guided Indovida completion on plan → NCLT approval pending (= PARTIAL)

Missed

  • Guided Europe margin to mid-teens → 10.4% (= MISS)
  • Guided EBITDA growth above revenue growth → EBITDA +17.6% vs revenue +30.0% (= MISS)
Source

Investor Presentation filed with NSE, NSE: EPL. Summary written with AI assistance from the document.

Read the document ↗

EPL Ltd: key numbers

Share price
₹222.00
Market cap
₹7,123 Cr
Revenue (annual)
₹4,763 Cr
Net profit (annual)
₹388.9 Cr
P/E (TTM)
18.4×Sector 45.0×
Promoter holding
0.00%+0.00% QoQ
FII holding
23.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from EPL Ltd

All →